We recently published 10 Stocks With Eye-Popping Double-Digit Gains. Hims & Hers Health, Inc. (NYSE:HIMS) is one of the ...

Telehealth platform Hims & Hers Health (NYSE:HIMS) shot to the top of stock charts yesterday as shares soared 16% high on no company news. While it is revolutionizing access to healthcare by ...

THEY have taken the nation’s waistlines by storm, helping thousands shed pounds and trim inches. So-called fat jabs have been dubbed a “miracle” – helping turn the tide on ...

The more cautious voices point to Hims’s high P/E ratio and recent volatility, warning that the stock could cool off after its sharp run-up. That said, a few analysts are still pretty optimistic. They ...

HIMS accelerates its global push with the ZAVA acquisition and a planned Canada launch targeting affordable obesity care.

A MOTHER has revealed that she has been battling “crazy” cravings for years – and it’s not due to being pregnant. Yaz Chapman ...

The market for generic GLP-1 weight loss drugs in Canada is set to open up, and Hims & Hers is ready to jump in.  | Novo ...

SAN FRANCISCO, July 09, 2025--Hims & Hers Health, Inc. (NYSE: HIMS) the leading digital health and wellness platform, today announced its plans to bring its affordable, holistic weight loss program to ...

Hims & Hers Announces Planned 2026 Expansion to Canada, Following ZAVA Acquisition Completion Entry to Canada will come as generic semaglutide hits the market for the first time, marking a major ...

With ZAVA now part of Hims & Hers, the company is scaling care across markets where its comprehensive offerings can meet consumer needs. The plans for Canada entry reflect continued progress on a ...

Hims & Hers Health, Inc. (NYSE: HIMS) the leading digital health and wellness platform, today announced its plans to bring its affordable, holistic weight loss program to Canada, timed with the ...

The doctor also revealed that weight loss medication might actually not do what people think, as research from ZAVA found up to 20% of people using the GLP-1 drugs don't see the expected results ...